首页 > 最新文献

Clinical Infection in Practice最新文献

英文 中文
Mycobacterium xenopi infection in an immunocompromised liver transplant recipient: A case report and comprehensive review 一名免疫力低下的肝移植受者感染了异种分枝杆菌:病例报告和综合综述
Q3 Medicine Pub Date : 2024-08-30 DOI: 10.1016/j.clinpr.2024.100384
Julie Lee, Kara Asbury, Rhea Ram

Mycobacterium xenopi, a nontuberculous mycobacterium (NTM), presents a significant diagnostic challenge in clinical practice, particularly in immunocompromised individuals. We report a case of M. xenopi infection in a liver transplant recipient on immunosuppressive medication. A 67-year-old male presented with chronic cough, anemia, and significant weight loss. Imaging studies revealed extensive pulmonary involvement with cavitations. More definitively, an acid-fast bacilli (AFB) bronchoalveolar lavage culture as well as an acid-fast bacilli (AFB) sputum culture confirmed M. xenopi infection. Treatment initiation with multiple antimicrobial agents was guided by susceptibility testing and published recommendations by the Infectious Disease Society of America and the American Thoracic Society guidelines from 2020 (Kurz, et al., 2020). This case emphasizes the importance of considering non-tubercular bacterial infections, particularly M. xenopi, in the differential diagnosis of respiratory symptoms in immunocompromised hosts. In addition to the case report, this paper provides a comprehensive review of the epidemiology, risk factors, clinical manifestations, diagnostic challenges, and treatment strategies for M. xenopi infections.

Xenopi 分枝杆菌是一种非结核分枝杆菌 (NTM),在临床实践中给诊断带来了巨大挑战,尤其是在免疫力低下的人群中。我们报告了一例使用免疫抑制剂的肝移植受者感染 M. xenopi 的病例。一名 67 岁的男性患者出现慢性咳嗽、贫血和体重明显减轻。影像学检查发现他的肺部广泛受累,并伴有空洞。更明确的是,支气管肺泡灌洗液培养和痰培养均证实感染了M. xenopi。在药敏试验以及美国传染病学会和美国胸科学会 2020 年指南(Kurz 等人,2020 年)公布的建议指导下,开始使用多种抗菌药物进行治疗。本病例强调了在鉴别诊断免疫力低下宿主的呼吸道症状时考虑非结核性细菌感染,尤其是疟原虫感染的重要性。除病例报告外,本文还全面综述了M. xenopi感染的流行病学、风险因素、临床表现、诊断难题和治疗策略。
{"title":"Mycobacterium xenopi infection in an immunocompromised liver transplant recipient: A case report and comprehensive review","authors":"Julie Lee,&nbsp;Kara Asbury,&nbsp;Rhea Ram","doi":"10.1016/j.clinpr.2024.100384","DOIUrl":"10.1016/j.clinpr.2024.100384","url":null,"abstract":"<div><p>Mycobacterium <em>xenopi</em>, a nontuberculous mycobacterium (NTM), presents a significant diagnostic challenge in clinical practice, particularly in immunocompromised individuals. We report a case of M. <em>xenopi</em> infection in a liver transplant recipient on immunosuppressive medication. A 67-year-old male presented with chronic cough, anemia, and significant weight loss. Imaging studies revealed extensive pulmonary involvement with cavitations. More definitively, an acid-fast bacilli (AFB) bronchoalveolar lavage culture as well as an acid-fast bacilli (AFB) sputum culture confirmed M. <em>xenopi</em> infection. Treatment initiation with multiple antimicrobial agents was guided by susceptibility testing and published recommendations by the Infectious Disease Society of America and the American Thoracic Society guidelines from 2020 (<span><span>Kurz, et al., 2020</span></span>). This case emphasizes the importance of considering non-tubercular bacterial infections, particularly M. <em>xenopi</em>, in the differential diagnosis of respiratory symptoms in immunocompromised hosts. In addition to the case report, this paper provides a comprehensive review of the epidemiology, risk factors, clinical manifestations, diagnostic challenges, and treatment strategies for M. <em>xenopi</em> infections.</p></div>","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100384"},"PeriodicalIF":0.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S259017022400044X/pdfft?md5=5f101ff1c67409266cf2d309bdbe1a5e&pid=1-s2.0-S259017022400044X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142233640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unusual pulmonary mycobacterial infection: Case report and literature review 不寻常的肺分枝杆菌感染:病例报告和文献综述
Q3 Medicine Pub Date : 2024-08-16 DOI: 10.1016/j.clinpr.2024.100382
Catriona Macrae, Nicholas Kennedy

Non-tuberculous mycobacteria (NTM) are mycobacterial species other than Mycobacterium tuberculosis complex (MTB) and the organisms that cause leprosy. They can cause pulmonary, central nervous system, lymph-node, joint, catheter-related as well as disseminated infection. NTM pulmonary disease (NTM-PD) occurs when NTM infection causes progressive inflammatory lung damage. NTM-PD is increasing in both incidence and prevalence. Mycobaterium szulgai, is an uncommon, slow-growing NTM. M. szulgai primarily causes pulmonary infections which present like MTB pulmonary infections. Due to low prevalence there are no standardised treatment guidelines for the management of M. szulgai infection.

We describe a case of M. szulgai pulmonary infection in diabetic man in his fifties who presented with productive cough, dyspnoea, weight loss, fatigue and night sweats. Computed tomography (CT) showed three thick walled cavities in the right lung, with consolidation, emphysema and adenopathy, thought to be reactive. Sputum samples were positive for acid alcohol fast bacilli (AAFB) but MTB PCR testing was negative. Sputum culture grew M. szulgai. He was treated with on Rifampicin, Isoniazid, Ethambutol and Azithromycin for 13 months. The patient improved significantly following initiation of anti-mycobacterial treatment.

The patient’s clinical presentation, radiological findings of upper lobe cavitating lesions, and characteristics; male, over 50 years old, immunosuppressed with underlying lung disease, are similar to most reported cases. M. szulgai can rarely infect immunocompetent hosts. Evidence to guide therapy is lacking. Treatment duration in the literature varies from six months to 39 months. Resistance to isoniazid has been reported and an isolate with both rifampicin and ethambutol resistance documented. Consensus guidelines recommend that NTM should be treated for at least 12 months from the first negative sputum culture. A combination of at least three susceptible drugs should be used, with rifampicin, ethambutol and azithromycin or clarithromycin recommended first line.

非结核分枝杆菌(NTM)是结核分枝杆菌复合体(MTB)和麻风病致病菌以外的分枝杆菌。它们可引起肺部、中枢神经系统、淋巴结、关节、导管相关以及播散性感染。NTM肺部疾病(NTM-PD)是指 NTM 感染引起的进行性肺部炎症损伤。NTM-PD的发病率和流行率都在不断上升。苏尔盖分枝杆菌是一种不常见、生长缓慢的非结核杆菌。M.szulgai主要引起肺部感染,表现与MTB肺部感染相似。我们描述了一例 50 多岁男性糖尿病患者的 M. szulgai 肺部感染病例,患者表现为有痰咳嗽、呼吸困难、体重减轻、乏力和盗汗。计算机断层扫描(CT)显示右肺有三个厚壁空洞,伴有肺不张、肺气肿和腺病,被认为是反应性肺炎。痰液样本中的酸性酒精快速杆菌(AAFB)呈阳性,但 MTB PCR 检测呈阴性。痰培养出了 M. szulgai。他接受了为期 13 个月的利福平、异烟肼、乙胺丁醇和阿奇霉素治疗。该患者的临床表现、上叶空洞性病变的放射学检查结果和特征(男性、50 岁以上、免疫抑制并伴有基础肺部疾病)与大多数报道的病例相似。M. szulgai很少感染免疫功能正常的宿主。目前还缺乏指导治疗的证据。文献中的治疗时间从 6 个月到 39 个月不等。对异烟肼产生耐药性的病例也有报道,有记录显示一个分离株同时对利福平和乙胺丁醇产生耐药性。共识指南建议,自首次痰培养阴性起,对非淋菌性肺结核的治疗至少应持续 12 个月。应使用至少三种易感药物联合治疗,建议首选利福平、乙胺丁醇和阿奇霉素或克拉霉素。
{"title":"An unusual pulmonary mycobacterial infection: Case report and literature review","authors":"Catriona Macrae,&nbsp;Nicholas Kennedy","doi":"10.1016/j.clinpr.2024.100382","DOIUrl":"10.1016/j.clinpr.2024.100382","url":null,"abstract":"<div><p>Non-tuberculous mycobacteria (NTM) are mycobacterial species other than <em>Mycobacterium tuberculosis</em> complex (MTB) and the organisms that cause leprosy. They can cause pulmonary, central nervous system, lymph-node, joint, catheter-related as well as disseminated infection. NTM pulmonary disease (NTM-PD) occurs when NTM infection causes progressive inflammatory lung damage. NTM-PD is increasing in both incidence and prevalence. <em>Mycobaterium szulgai</em>, is an uncommon, slow-growing NTM. <em>M. szulgai</em> primarily causes pulmonary infections which present like MTB pulmonary infections. Due to low prevalence there are no standardised treatment guidelines for the management of <em>M. szulgai</em> infection.</p><p>We describe a case of <em>M. szulgai</em> pulmonary infection in diabetic man in his fifties who presented with productive cough, dyspnoea, weight loss, fatigue and night sweats. Computed tomography (CT) showed three thick walled cavities in the right lung, with consolidation, emphysema and adenopathy, thought to be reactive. Sputum samples were positive for acid alcohol fast bacilli (AAFB) but MTB PCR testing was negative. Sputum culture grew <em>M. szulgai</em>. He was treated with on Rifampicin, Isoniazid, Ethambutol and Azithromycin for 13 months. The patient improved significantly following initiation of anti-mycobacterial treatment.</p><p>The patient’s clinical presentation, radiological findings of upper lobe cavitating lesions, and characteristics; male, over 50 years old, immunosuppressed with underlying lung disease, are similar to most reported cases. <em>M. szulgai</em> can rarely infect immunocompetent hosts. Evidence to guide therapy is lacking. Treatment duration in the literature varies from six months to 39 months. Resistance to isoniazid has been reported and an isolate with both rifampicin and ethambutol resistance documented. Consensus guidelines recommend that NTM should be treated for at least 12 months from the first negative sputum culture. A combination of at least three susceptible drugs should be used, with rifampicin, ethambutol and azithromycin or clarithromycin recommended first line.</p></div>","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100382"},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590170224000426/pdfft?md5=569c047973d5a7ecf5e4792db4e04376&pid=1-s2.0-S2590170224000426-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142021136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculosis the great mimicker: Five unusual cases 肺结核是伟大的模仿者:五个不寻常的病例
Q3 Medicine Pub Date : 2024-08-16 DOI: 10.1016/j.clinpr.2024.100383
Shohael Mahmud Arafat, Chowdhury Adnan Sami, Sudip Kumar Banik, Refaya Tasnim, Nazmun Naher, Md Altaf Hossain, Md Mizanur Rahman Khan, Abed Hussain Khan

Background

There are wide varieties of clinical manifestations of Tuberculosis (TB). Extrapulmonary tuberculosis (EPTB) patients usually come with an atypical presentation, are difficult to suspect, and frequently involve sites that are very hard to access, and invasive procedures are usually required for diagnosis. We are presenting five cases of atypical presentations of TB here.

Case reports

The first case presented acute flaccid paraparesis with right loin pain, ultimately diagnosed as tubercular psoas abscess inducing acute inflammatory demyelinating polyneuropathy. The second case presented with hematemesis, dysphagia, weight loss, and a rare case of esophageal TB was diagnosed. The third case presented with painful multiple bony lytic lesions and was diagnosed as a case of multifocal skeletal TB. The fourth case presented multiple abscesses at different skin sites, leading to a diagnosis of metastatic tubercular abscesses. The fifth case was an elderly female who presented with right hip joint pain, eventually diagnosed as tubercular hip arthritis.

Conclusion

EPTB is a great mimicker and has been a challenging medical condition due to the divergence of presentations. High clinical suspicion and vigilance can lead to an early diagnosis and survival of patients.

背景肺结核(TB)的临床表现多种多样。肺外结核(EPTB)患者通常表现不典型,很难被怀疑,而且常常涉及难以触及的部位,通常需要进行侵入性手术才能确诊。我们在此介绍五例表现不典型的肺结核病例。第一例出现急性弛缓性截瘫,伴右腰部疼痛,最终诊断为结核性腰大肌脓肿诱发急性炎症性脱髓鞘性多发性神经病。第二个病例出现吐血、吞咽困难、体重减轻,诊断为罕见的食管结核。第三个病例出现疼痛的多发性骨骼溶解性病变,被诊断为多灶性骨骼结核。第四例患者在不同皮肤部位出现多个脓肿,诊断为转移性结核脓肿。第五个病例是一名老年女性,表现为右髋关节疼痛,最终被诊断为结核性髋关节炎。临床上的高度怀疑和警惕可使患者得到早期诊断并存活下来。
{"title":"Tuberculosis the great mimicker: Five unusual cases","authors":"Shohael Mahmud Arafat,&nbsp;Chowdhury Adnan Sami,&nbsp;Sudip Kumar Banik,&nbsp;Refaya Tasnim,&nbsp;Nazmun Naher,&nbsp;Md Altaf Hossain,&nbsp;Md Mizanur Rahman Khan,&nbsp;Abed Hussain Khan","doi":"10.1016/j.clinpr.2024.100383","DOIUrl":"10.1016/j.clinpr.2024.100383","url":null,"abstract":"<div><h3>Background</h3><p>There are wide varieties of clinical manifestations of Tuberculosis (TB). Extrapulmonary tuberculosis (EPTB) patients usually come with an atypical presentation, are difficult to suspect, and frequently involve sites that are very hard to access, and invasive procedures are usually required for diagnosis. We are presenting five cases of atypical presentations of TB here.</p></div><div><h3>Case reports</h3><p>The first case presented acute flaccid paraparesis with right loin pain, ultimately diagnosed as tubercular psoas abscess inducing acute inflammatory demyelinating polyneuropathy. The second case presented with hematemesis, dysphagia, weight loss, and a rare case of esophageal TB was diagnosed. The third case presented with painful multiple bony lytic lesions and was diagnosed as a case of multifocal skeletal TB. The fourth case presented multiple abscesses at different skin sites, leading to a diagnosis of metastatic tubercular abscesses. The fifth case was an elderly female who presented with right hip joint pain, eventually diagnosed as tubercular hip arthritis.</p></div><div><h3>Conclusion</h3><p>EPTB is a great mimicker and has been a challenging medical condition due to the divergence of presentations. High clinical suspicion and vigilance can lead to an early diagnosis and survival of patients.</p></div>","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100383"},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590170224000438/pdfft?md5=9e2b89e54c69bc21298922e010410d28&pid=1-s2.0-S2590170224000438-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142077503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tools for optimising clinical consultation activity in infection services in the United Kingdom 优化英国感染服务临床咨询活动的工具
Q3 Medicine Pub Date : 2024-08-10 DOI: 10.1016/j.clinpr.2024.100378
Natasha V.D.V. Ratnaraja , Angharad P. Davies , Harriet Hughes , Clinical Services Committee working group on tools

Demands on infection services have significantly increased over recent years, covering a diverse and broad range of clinical activities (Lawrence et al, 2021). This has not been accompanied by a corresponding increase in resources. The term Infection Specialist equally covers a broad and diverse range of specialities, and what is defined as one type of clinical infection review/consult may differ between infection specialists and infection services. This has also made it difficult to accurately capture clinical activity. Documentation of clinical activity may also be challenging, and also prevent accurate capture of the amount and type of activity being undertaken.

This document aims to provide a standardised description of the different types of clinical infection reviews. It aims to guide referrers to the minimum information required to optimise each type of review, to optimise the consultation. There are also suggested tools which may help infection services document and capture their clinical activity.

近年来,对感染服务的需求大幅增加,涉及多种多样的临床活动(Lawrence 等人,2021 年)。与此同时,资源却没有相应增加。感染专科医师一词同样涵盖了广泛而多样的专科,感染专科医师和感染服务机构对某一类型临床感染审查/咨询的定义可能有所不同。这也给准确掌握临床活动带来了困难。本文件旨在对不同类型的临床感染审查进行标准化描述。本文件旨在对不同类型的临床感染复查进行标准化描述,指导转介者优化每种类型的复查所需的最低限度信息,以优化会诊。本文件还提供了一些建议工具,可帮助感染服务部门记录和捕捉其临床活动。
{"title":"Tools for optimising clinical consultation activity in infection services in the United Kingdom","authors":"Natasha V.D.V. Ratnaraja ,&nbsp;Angharad P. Davies ,&nbsp;Harriet Hughes ,&nbsp;Clinical Services Committee working group on tools","doi":"10.1016/j.clinpr.2024.100378","DOIUrl":"10.1016/j.clinpr.2024.100378","url":null,"abstract":"<div><p>Demands on infection services have significantly increased over recent years, covering a diverse and broad range of clinical activities (Lawrence et al, 2021). This has not been accompanied by a corresponding increase in resources. The term Infection Specialist equally covers a broad and diverse range of specialities, and what is defined as one type of clinical infection review/consult may differ between infection specialists and infection services. This has also made it difficult to accurately capture clinical activity. Documentation of clinical activity may also be challenging, and also prevent accurate capture of the amount and type of activity being undertaken.</p><p>This document aims to provide a standardised description of the different types of clinical infection reviews. It aims to guide referrers to the minimum information required to optimise each type of review, to optimise the consultation. There are also suggested tools which may help infection services document and capture their clinical activity.</p></div>","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100378"},"PeriodicalIF":0.0,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590170224000384/pdfft?md5=c106d4b84371233ae7ba40f7946212d4&pid=1-s2.0-S2590170224000384-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142163906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The revolutionary impact of monoclonal antibodies in malaria prevention 单克隆抗体对疟疾预防的革命性影响
Q3 Medicine Pub Date : 2024-08-04 DOI: 10.1016/j.clinpr.2024.100374
Vijay Kumar , Mahalaqua Nazli Khatib , Shilpa Gaidhane , Sarvesh Rustagi , Edward Mawejje , Prakasini Satapathy
{"title":"The revolutionary impact of monoclonal antibodies in malaria prevention","authors":"Vijay Kumar ,&nbsp;Mahalaqua Nazli Khatib ,&nbsp;Shilpa Gaidhane ,&nbsp;Sarvesh Rustagi ,&nbsp;Edward Mawejje ,&nbsp;Prakasini Satapathy","doi":"10.1016/j.clinpr.2024.100374","DOIUrl":"10.1016/j.clinpr.2024.100374","url":null,"abstract":"","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100374"},"PeriodicalIF":0.0,"publicationDate":"2024-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590170224000347/pdfft?md5=a80b32e9c4ce56b500ef9eb9cecd0303&pid=1-s2.0-S2590170224000347-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141953430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enteric fever in a non-endemic setting: Review of cases over a 12-year period at University hospitals Birmingham, UK 非流行环境中的肠热病:英国伯明翰大学医院 12 年来的病例回顾
Q3 Medicine Pub Date : 2024-08-03 DOI: 10.1016/j.clinpr.2024.100380
Gareth Hughes , Rania Khalil , Susan Wilkinson , Matthew K. O’Shea

Objectives

Enteric fever remains a common diagnosis in returned travellers to the UK, the majority of which require hospital admission. Increased resistance to antibiotics has complicated the management and rates of vaccine uptake remain unclear.

Methods

We performed a retrospective study of culture-confirmed cases of enteric fever from blood samples in patients admitted to University Hospitals Birmingham, UK, between January 2010 and June 2022 to assess antimicrobial susceptibility, treatment outcomes and vaccination uptake.

Results

In total, 108 patients were identified during the time period (S.typhi n = 57 [53 %]; S.paratyphi n = 51 [47 %]). Nearly all (93 % [100/108]) had returned from South Asia. There was no evidence of typhoid vaccination pre-travel for most patients (n = 96 [89 %]) in both groups. Over half of patients with S.typhi had microbiologically positive stool samples compared to just over 20 % of the S. paratyphi group (20/36 [55 %] vs 5/23 [22 %], p = 0.015). Three cases of ceftriaxone resistant enteric fever occurred.

Conclusion

Enteric fever remains a frequent presentation to a non-endemic setting with close links to high-endemic regions such as South Asia. Vaccination uptake among local populations could be improved. Few cases of ceftriaxone-resistant enteric fever were seen which is a consideration for improved antimicrobial stewardship.

目的 肠热病仍然是英国回国旅行者的常见诊断病症,其中大多数人需要入院治疗。方法 我们对 2010 年 1 月至 2022 年 6 月期间英国伯明翰大学医院收治的肠道热患者的血液样本中经培养确诊的肠道热病例进行了回顾性研究,以评估抗菌药敏感性、治疗效果和疫苗接种率。几乎所有患者(93% [100/108])都是从南亚返回的。两组中的大多数患者(n = 96 [89%])在旅行前均未接种伤寒疫苗。半数以上的伤寒患者粪便样本微生物学呈阳性,而副伤寒患者中仅有 20% 多一点(20/36 [55 %] vs 5/23 [22 %],P = 0.015)。结论 肠热病仍是非流行地区的常见病,但与南亚等高端流行地区密切相关。当地居民的疫苗接种率有待提高。耐头孢曲松肠炎病例很少,这也是改进抗菌药物管理的一个考虑因素。
{"title":"Enteric fever in a non-endemic setting: Review of cases over a 12-year period at University hospitals Birmingham, UK","authors":"Gareth Hughes ,&nbsp;Rania Khalil ,&nbsp;Susan Wilkinson ,&nbsp;Matthew K. O’Shea","doi":"10.1016/j.clinpr.2024.100380","DOIUrl":"10.1016/j.clinpr.2024.100380","url":null,"abstract":"<div><h3>Objectives</h3><p>Enteric fever remains a common diagnosis in returned travellers to the UK, the majority of which require hospital admission. Increased resistance to antibiotics has complicated the management and rates of vaccine uptake remain unclear.</p></div><div><h3>Methods</h3><p>We performed a retrospective study of culture-confirmed cases of enteric fever from blood samples in patients admitted to University Hospitals Birmingham, UK, between January 2010 and June 2022 to assess antimicrobial susceptibility, treatment outcomes and vaccination uptake.</p></div><div><h3>Results</h3><p>In total, 108 patients were identified during the time period (<em>S.typhi</em> n = 57 [53 %]; <em>S.paratyphi</em> n = 51 [47 %]). Nearly all (93 % [100/108]) had returned from South Asia. There was no evidence of typhoid vaccination pre-travel for most patients (n = 96 [89 %]) in both groups. Over half of patients with S.<em>typhi</em> had microbiologically positive stool samples compared to just over 20 % of the <em>S. paratyphi</em> group (20/36 [55 %] vs 5/23 [22 %], p = 0.015). Three cases of ceftriaxone resistant enteric fever occurred.</p></div><div><h3>Conclusion</h3><p>Enteric fever remains a frequent presentation to a non-endemic setting with close links to high-endemic regions such as South Asia. Vaccination uptake among local populations could be improved. Few cases of ceftriaxone-resistant enteric fever were seen which is a consideration for improved antimicrobial stewardship.</p></div>","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100380"},"PeriodicalIF":0.0,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590170224000402/pdfft?md5=2c1d4cec2b2ec0d49739c471f9c9cae2&pid=1-s2.0-S2590170224000402-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141953431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chandipura Virus Outbreaks: An Emerging Threat or Sporadic Epidemics? 钱迪普拉病毒爆发:新出现的威胁还是零星的流行病?
Q3 Medicine Pub Date : 2024-08-02 DOI: 10.1016/j.clinpr.2024.100379
Amogh Verma , Nivedita Singh , Amna Zaheer , Sanjit Sah , Mahendra Pratap Singh
{"title":"Chandipura Virus Outbreaks: An Emerging Threat or Sporadic Epidemics?","authors":"Amogh Verma ,&nbsp;Nivedita Singh ,&nbsp;Amna Zaheer ,&nbsp;Sanjit Sah ,&nbsp;Mahendra Pratap Singh","doi":"10.1016/j.clinpr.2024.100379","DOIUrl":"10.1016/j.clinpr.2024.100379","url":null,"abstract":"","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100379"},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590170224000396/pdfft?md5=e58fc43acf8048238d921b5752caf341&pid=1-s2.0-S2590170224000396-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Commentary from the BIA Clinical Services Committee on Infection Quick Reference Guides: Resources to Promote Appropriate Testing for Infection Presentations BIA 临床服务委员会关于感染快速参考指南的编辑评论:促进对感染进行适当检测的资源介绍
Q3 Medicine Pub Date : 2024-07-29 DOI: 10.1016/j.clinpr.2024.100375
David George Partridge, on behalf of the British Infection Association Clinical Services Committee
{"title":"Editorial Commentary from the BIA Clinical Services Committee on Infection Quick Reference Guides: Resources to Promote Appropriate Testing for Infection Presentations","authors":"David George Partridge,&nbsp;on behalf of the British Infection Association Clinical Services Committee","doi":"10.1016/j.clinpr.2024.100375","DOIUrl":"10.1016/j.clinpr.2024.100375","url":null,"abstract":"","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100375"},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590170224000359/pdfft?md5=9a46af50ec7d894839ac13321d8066be&pid=1-s2.0-S2590170224000359-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142172115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Odisha’s diphtheria fight: A reminder for strengthening response capacities 奥迪沙的白喉防治工作:加强应对能力的提醒
Q3 Medicine Pub Date : 2024-07-20 DOI: 10.1016/j.clinpr.2024.100373
Ayush Sharma , Jigisha Anand , Mahalaqua Nazli Khatib , Quazi Syed Zahiruddin , Mahendra Pratap Singh , Sanjit Sah
{"title":"Odisha’s diphtheria fight: A reminder for strengthening response capacities","authors":"Ayush Sharma ,&nbsp;Jigisha Anand ,&nbsp;Mahalaqua Nazli Khatib ,&nbsp;Quazi Syed Zahiruddin ,&nbsp;Mahendra Pratap Singh ,&nbsp;Sanjit Sah","doi":"10.1016/j.clinpr.2024.100373","DOIUrl":"10.1016/j.clinpr.2024.100373","url":null,"abstract":"","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"24 ","pages":"Article 100373"},"PeriodicalIF":0.0,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590170224000335/pdfft?md5=df223d7f6c5e618f8f19a42093236947&pid=1-s2.0-S2590170224000335-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141852696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of an infected wound complicated by osteomyelitis secondary to neuropathy caused by previous leprosy; successful treatment with gauze ribbon, Multivitamins, and maggot therapy 处理因麻风病引起的神经病变而继发骨髓炎的感染性伤口;使用纱布带、多种维生素和蛆虫疗法成功治疗了伤口
Q3 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.clinpr.2024.100370
Mohammad Reza Faramarzi , Golnar Abbasi Farid , Behnam Babamiri , Hiva Lotfy , Rasoul Goli , Navid Faraji , Milad Ahangarzadeh

Introduction

Neuropathy, particularly commonly seen in the form of benign osteomyelitis, is a leading cause of wound formation and severe bone deformity. Leprosy, a chronic disease caused by Mycobacterium leprae and Mycobacterium lepromatosis, initially presents with asymptomatic infections that can remain so for 5 to 20 years. Hansen’s disease, caused by Mycobacterium leprae, presents a disease spectrum influenced by the patient’s immune response, ranging from tuberculoid to lepromatous.

Case presentation:

In this case study, maggot therapy was utilized as a novel method to address the wound. This study aimed to heal a wound and prevent amputation in a 76-year-old leprosy patient with osteomyelitis of the metatarsophalangeal joint. Diagnosed with leprosy at 45, he presented numbness in his legs up to the waist and hand, indicating neuropathy. The condition, linked to inadequate joint care, led to osteomyelitis. The patient sought treatment due to a wound in the metatarsophalangeal area.

Laboratory tests, wound cultures, and imaging studies revealed positive results for osteomyelitis, prompting consideration of leg amputation. However, preservation of the leg without amputation through joint and bone osteotomy was successfully achieved, demonstrating an alternative to amputation in select cases.

Conclusion

This study underscores the importance of tailored and multidisciplinary approaches in addressing challenging wound healing issues in patients with leprosy. It emphasizes the significance of individualized care and the potential benefits of integrating diverse therapeutic interventions to achieve successful outcomes.

导言神经病变,特别是常见的良性骨髓炎,是伤口形成和严重骨骼畸形的主要原因。麻风病是由麻风分枝杆菌和麻风疫霉菌引起的一种慢性疾病,最初表现为无症状感染,可持续 5 到 20 年。汉森氏病由麻风分枝杆菌引起,受患者免疫反应的影响,疾病谱从结核型到麻风型不等。病例介绍:在本病例研究中,蛆疗法作为一种新方法被用来治疗伤口。本研究旨在治愈一名 76 岁麻风病人的伤口,防止其截肢,该病人患有跖趾关节骨髓炎。他 45 岁时被诊断出患有麻风病,双腿至腰部和手部麻木,这表明他患有神经病变。这种情况与关节护理不当有关,导致骨髓炎。患者因跖趾骨部位的伤口就医。实验室检查、伤口培养和影像学检查结果显示骨髓炎呈阳性,因此考虑截肢。然而,通过关节和骨骼截骨术,患者成功保住了腿部而没有截肢,这表明在特定病例中,截肢是一种替代疗法。它强调了个体化护理的重要性,以及整合多种治疗干预措施以取得成功结果的潜在益处。
{"title":"Management of an infected wound complicated by osteomyelitis secondary to neuropathy caused by previous leprosy; successful treatment with gauze ribbon, Multivitamins, and maggot therapy","authors":"Mohammad Reza Faramarzi ,&nbsp;Golnar Abbasi Farid ,&nbsp;Behnam Babamiri ,&nbsp;Hiva Lotfy ,&nbsp;Rasoul Goli ,&nbsp;Navid Faraji ,&nbsp;Milad Ahangarzadeh","doi":"10.1016/j.clinpr.2024.100370","DOIUrl":"10.1016/j.clinpr.2024.100370","url":null,"abstract":"<div><h3>Introduction</h3><p>Neuropathy, particularly commonly seen in the form of benign osteomyelitis, is a leading cause of wound formation and severe bone deformity. Leprosy, a chronic disease caused by Mycobacterium leprae and Mycobacterium lepromatosis, initially presents with asymptomatic infections that can remain so for 5 to 20 years. Hansen’s disease, caused by Mycobacterium leprae, presents a disease spectrum influenced by the patient’s immune response, ranging from tuberculoid to lepromatous.</p><p>Case presentation:</p><p>In this case study, maggot therapy was utilized as a novel method to address the wound. This study aimed to heal a wound and prevent amputation in a 76-year-old leprosy patient with osteomyelitis of the metatarsophalangeal joint. Diagnosed with leprosy at 45, he presented numbness in his legs up to the waist and hand, indicating neuropathy. The condition, linked to inadequate joint care, led to osteomyelitis. The patient sought treatment due to a wound in the metatarsophalangeal area.</p><p>Laboratory tests, wound cultures, and imaging studies revealed positive results for osteomyelitis, prompting consideration of leg amputation. However, preservation of the leg without amputation through joint and bone osteotomy was successfully achieved, demonstrating an alternative to amputation in select cases.</p></div><div><h3>Conclusion</h3><p>This study underscores the importance of tailored and multidisciplinary approaches in addressing challenging wound healing issues in patients with leprosy. It emphasizes the significance of individualized care and the potential benefits of integrating diverse therapeutic interventions to achieve successful outcomes.</p></div>","PeriodicalId":33837,"journal":{"name":"Clinical Infection in Practice","volume":"23 ","pages":"Article 100370"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S259017022400030X/pdfft?md5=8097b07f7495dfea206b2ec1a4f6012c&pid=1-s2.0-S259017022400030X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141962197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Infection in Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1